Bio & Insurance Information

Dr. Richard Just graduated from the Rosalind Franklin University of Medicine and Science and then did his internship and Internal Medicine residency at the VA Greater Los Angeles Healthcare System. He has also completed a residency in Internal Medicine at the University of California, San Diego. Dr. Just has received certifications from the American Board of Internal Medicine in the field of Medical Oncology, Internal Medicine, and Hematology. He has been practicing for more than two decades and is currently affiliated with multiple hospitals such as the Palomar Medical Center, Pomerado Hospital, Tri-City Medical Center, and Scripps Memorial Hospital, La Jolla. Dr. Just has also contributed to several research papers.



Education & Training

Rosalind Franklin University of Medicine and Science

Medical School

VA Greater Los Angeles Healthcare System

Internship

University of California San Diego

Residency

VA Greater Los Angeles Healthcare System

Residency

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine - Hematology

American Board of Internal Medicine - Oncology

Hospitals & Clinics

Palomar Medical Center

Languages: English/Spanish

(442) 281-5000

2185 Citracado Parkway

Escondido, California 92029

Read More

Pomerado Hospital

Languages: English/Spanish

(858) 613-4000

15615 Pomerado Rd

Poway, California 92064

Read More

Scripps Memorial Hospital La Jolla

Languages: English/Spanish

(858) 626-4123

9888 Genesee Ave

La Jolla, California 92037

Read More

Tri City Medical Center

Languages: English/Spanish

(760) 724-8411

4002 Vista Way

Oceanside, California 92056

Read More

Publications

Dr. Richard Just has contributed to 2 publications.

Phase 1 dose-escalation trial evaluating the combination of the selective MET (mesenchymal-epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib.

Goldman, J. W., Laux, I., Chai, F., Savage, R. E., Ferrari, D., Garmey, E. G., Just, R. G., Rosen, L. S.; Cancer. 2012 Dec 1.

See more >>

Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses.

Redfern, C.H., Guthrie, T.H., Bessudo, A., Densmore, J.J., Holman, P.R., Janakiraman, N., Leonard, J.P., Levy, R.L., Just, R.G., Smith, M.R., Rosenfelt, F.P., Wiernik,...; J Clin Oncol. 2006 Jul 1.

See more >>

Memberships

American College of Physicians